News
Amplia Therapeutics (ASX: ATX) continues to make excellent progress with focal adhesion kinase (FAK) inhibitor narmafotinib, ...
Sprintex (ASX: SIX) has secured a $377,000 order from Türkish distributor Net 0 Enerji for the supply of high-capacity G ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback